IRIS
BOCCARDO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 39.173
AS - Asia 1.214
SA - Sud America 213
NA - Nord America 178
AF - Africa 26
Totale 40.804
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 39.136
SG - Singapore 547
CN - Cina 354
VN - Vietnam 203
BR - Brasile 140
US - Stati Uniti d'America 139
AR - Argentina 41
HK - Hong Kong 33
MX - Messico 32
ID - Indonesia 15
BD - Bangladesh 14
IQ - Iraq 10
EC - Ecuador 9
PL - Polonia 8
VE - Venezuela 8
GB - Regno Unito 6
IN - India 6
RU - Federazione Russa 6
MA - Marocco 5
PY - Paraguay 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
ES - Italia 4
CO - Colombia 3
JO - Giordania 3
KE - Kenya 3
PK - Pakistan 3
SE - Svezia 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
AT - Austria 2
CA - Canada 2
CI - Costa d'Avorio 2
CL - Cile 2
DO - Repubblica Dominicana 2
JP - Giappone 2
LT - Lituania 2
PE - Perù 2
RE - Reunion 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DE - Germania 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
UA - Ucraina 1
UG - Uganda 1
YE - Yemen 1
Totale 40.804
Salva come PNG Salva come JPEG
Città #
Genova 25.260
Genoa 8.185
Rapallo 3.374
Vado Ligure 2.245
Singapore 305
Beijing 80
Ho Chi Minh City 69
Bordighera 65
Ashburn 62
Hanoi 48
Hong Kong 31
Tianjin 24
Mexico City 21
São Paulo 17
Los Angeles 11
Haiphong 9
Biên Hòa 8
New York 7
Warsaw 7
Bắc Ninh 6
Hải Dương 6
Jakarta 6
Curitiba 5
Guangzhou 5
Thái Nguyên 5
Council Bluffs 4
Lanús 4
Orem 4
Porto Alegre 4
San Jose 4
Amman 3
Baku 3
Buenos Aires 3
Da Nang 3
Johannesburg 3
Marrakesh 3
Newark 3
Phủ Lý 3
Quảng Ngãi 3
Santa Clara 3
Shanghai 3
Stockholm 3
São José do Rio Preto 3
Tây Ninh 3
Volta Redonda 3
Abidjan 2
Agawam 2
Asunción 2
Baghdad 2
Belo Horizonte 2
Birmingham 2
Blumenau 2
Boardman 2
Brasília 2
Bình Dương 2
Bến Cầu 2
Camaçari 2
Caracas 2
Carney 2
Changsha 2
Concepción 2
Cuiabá 2
Duque de Caxias 2
Fortaleza 2
Fuzhou 2
Goiânia 2
Guayaquil 2
Jaboatão dos Guararapes 2
La Plata 2
Lagoa Vermelha 2
Mogi Guaçu 2
Monte Grande 2
Montreal 2
Nairobi 2
Naples 2
Orangeburg 2
Poplar 2
Quito 2
Quận Bình Thạnh 2
Quận Ninh Kiều 2
Recife 2
Reconquista 2
Resistencia 2
Rondon do Pará 2
Salvador 2
San Juan 2
Tashkent 2
Teramo 2
Tokyo 2
Uberlândia 2
Villa José León Suárez 2
Vĩnh Long 2
Vĩnh Tường 2
Wuhan 2
Addis Ababa 1
Almirante Brown 1
Ambato 1
Americana 1
Aparecida de Goiânia 1
Araguari 1
Totale 40.030
Salva come PNG Salva come JPEG
Nome #
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome 232
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years 220
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer 207
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 196
Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials 195
A Case of Advanced Mucinous Adenocarcinoma of Bladder in an Adult Patient Treated With Capecitabine-Based Chemotherapy and Review of Literature 192
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer 187
A Case of Plasmacytoid Variant of Bladder Cancer with a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature 182
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer 180
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. 178
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer 177
Efficacy of motesanib diphosphate in non-small-cell lung cancer. 175
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 174
A hnRNP K–AR-related signature reflects progression toward castration-resistant prostate cancer 173
Apalutamide treatment and metastasis-free survival in prostate cancer 173
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials 170
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 169
Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines. 167
Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy. 167
Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy 167
Management of young women with early breast cancer 166
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. 165
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials 165
Prognostic value of preoperative serum levels of periostin (PN) in early breast cancer (BCa) 163
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma 162
Differential expression of nuclear lamins in normal and cancerous prostate tissues 161
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report 161
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 161
Adjuvant chemotherapy of bladder cancer. 160
Next Generation Sequencing In Non-Small Cell Lung Cancer: New Avenues Toward The Personalized Medicine. 159
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 158
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer 158
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma 157
Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study 155
Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy 155
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: Meta-analysis of individual patient data from ten randomised trials 154
Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study 153
May adjuvant therapy play a role for the management of renal cell carcinoma? A review of literature and ongoing trials 152
Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery 152
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer 151
Belagenpumatucel-L for the treatment of non-small cell lung cancer 151
Adjuvant therapy for patients with node negative breast cancer. 150
Targeting androgen-independent pathways: new chances for patients with prostate cancer? 150
Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast 149
Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results 149
Paclitaxel plus organoplatins: still the gold standard in advanced ovarian cancer? 148
Survival prediction in everolimus-treated patients with metastatic renal cell carcinoma incorporating tumor burden response in the RECORD-1 trial. 148
Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. 148
Alternating chemo-radiotherapy in bladder cancer: a conservative approach. 147
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial 147
Ovarian ablation in early breast cancer: overview of the randomised trials. 146
Urethral stricture and scrotal abscess: a rare case presentation of penile cancer and review of the literature 146
Leiomyosarcoma of the broad ligament: a case report and review of literature. 145
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. 145
Combinations of hormonal therapy and chemotherapy 145
Bone metastases from prostate cancer: hormonal therapy 145
Genitourinary tumours in the targeted therapies era: New advances in clinical practice and future perspectives 144
Priming action on progesterone receptor synthesis by estradiol and tamoxifen in the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma. 143
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death 143
Periostin: A Novel Prognostic and Therapeutic Target For Genitourinary Cancer? 143
D-TRP-6-LH-RH treatment of advanced prostatic cancer 143
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial. 143
Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question! 143
Switching to aromatase inhibitors in early breast cancer. 143
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials 143
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials 142
Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients. 141
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. 141
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer. 141
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 141
Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature. 140
Immunotherapy for genitourinary cancer: State of the art and new perspectives 140
68P * Prognostic value of periostin (PN) expression in early breast cancer (BCa): Long-term mortality outcomes 139
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis 139
Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate cancer. 138
Communicating cancer diagnosis and prognosis: when the target is the elderly patient-a GIOGer study. 138
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. 138
Prognostic value of nuclear matrix protein expression in localized prostate cancer. 138
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials 138
A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group. 137
Use of metronomic chemotherapy in oncology: results from a national Italian survey. 137
Re: j. Alfred witjes. A case of abiraterone acetate withdrawal. Eur urol 2013;64:517-8. 137
Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer. 137
Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial. 136
Prognostic factors in patients receiving third-line targeted therapy for metastatic renal cell carcinoma. 136
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 136
Carboplatin in advanced hormone refractory prostatic cancer patients. 135
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer. 135
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Long term results of the Italian Tamoxifen Anastrozole trial. 135
Oral vinorelbine in the treatment of non-small-cell lung cancer. 134
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 134
R75251 in prostate cancer patients in progression after first-line hormonal treatment. 133
Ifosfamide in urologic cancer. 133
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study 133
Italian national consensus conference on prostate cancer screening (Florence, May 17, 2003)--final consensus document. 133
Presence and distribution of growth factors in breast cyst fluid. 132
Somatuline and tamoxifen in postmenopausal breast cancer patients. 132
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen. Results of the GROCTA trial. 132
Chemotherapy with cisplatin and 5-fluorouracil chronomodulated infusion in locally advanced or metastatic/recurrent carcinoma of the cervix. 132
Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from 223Ra-dichloride to new horizons for therapeutic response assessment 132
Totale 15.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.620
article - articoli 117.351
book - libri 609
conference - conferenze 260
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.400
Totale 261.240
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.697 0 0 0 0 0 382 102 215 233 284 217 264
2021/20224.214 105 289 202 604 152 290 132 1.154 233 379 96 578
2022/20234.052 409 225 46 383 741 831 7 272 729 30 317 62
2023/20241.832 85 294 46 205 154 317 99 113 84 61 94 280
2024/20255.476 130 458 218 402 719 539 482 884 223 262 470 689
2025/20264.215 1.031 311 661 742 1.274 196 0 0 0 0 0 0
Totale 41.514